Page last updated: 2024-09-05

technetium tc 99m pentetate and Hyperkyphosis

technetium tc 99m pentetate has been researched along with Hyperkyphosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blackshaw, PE; Dansereau, RJ; Fairbairn, KJ; Frier, M; Hosking, D; Kinghorn, T; Perkins, AC; San, P; Spiller, RC1

Trials

1 trial(s) available for technetium tc 99m pentetate and Hyperkyphosis

ArticleYear
Esophageal transit of the weekly film-coated risedronate (Actonel) placebo tablet in subjects with Kyphosis.
    International journal of pharmaceutics, 2006, Mar-27, Volume: 311, Issue:1-2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Bone Density Conservation Agents; Esophagus; Etidronic Acid; Female; Gastric Emptying; Gastrointestinal Transit; Humans; Kyphosis; Male; Middle Aged; Radionuclide Imaging; Risedronic Acid; Severity of Illness Index; Tablets, Enteric-Coated; Technetium Tc 99m Pentetate; Water

2006